Spellman David A
- SEC CIK
- 0001733204
No open-market purchases or sales filed in the past year.
Current role at each company
- AKBA Akebia Therapeutics, Inc.SVP, CFO and Treasureras of May 18, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Spellman David A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 (view filing) | May 16 | 2 days | Spellman David ASVP, CFO and Treasurer | SSale | −63.6K | $1.07 | −$68.0K | −12.5%446.5K after | |
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Spellman David ASVP, CFO and Treasurer | SSale | −7.21K | $0.88 | −$6.34K | −1.4%510.1K after | 2 lots |
| Mar 1, 2023 (view filing) | Feb 27 | 2 days | Spellman David ASVP, CFO and Treasurer | SSale | −7.54K | $0.81 | −$6.11K | −1.4%517.3K after | |
| Mar 2, 2022 (view filing) | Feb 28-Mar 1 | 2 days | Spellman David ASVP, CFO and Treasurer | SSale | −8.20K | $2.15 | −$17.7K | −6.0%128.6K after | 2 lots |